95.043 Prescription Drug Value Based Contracting

95.043

Prescription Drug Value Based Contracting: While the Texas Medical Association applauds innovative ways to make prescription drugs more available and affordable for patients, TMA believes that doing so without physician input may be construed as the corporate practice of medicine. Therefore, TMA insists that direct care physicians be included in the development of any new contracting programs to ensure that physician and, more importantly, patient interests are considered. In no way should value-based contracting or any other contracting method be a hindrance between the physician and the drugs the physician believes is the best treatment for his or her patient (CSE Rep. 4-A-17).

Last Updated On

June 06, 2017